Trump looking at cutting drug prices to international levels, Reuters says

Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid by other developed countries, according to two company sources who called the option the pharmaceutical industry’s top concern, Reuters’ Patrick Wingrove reports. Both sources said they expected the policy to come from the agency that oversees Medicare and Medicaid health programs.